Objective: Carotid intervention is safe and effective in stroke prevention in appropriately selected patients. Despite minimal neurologic complications, procedure-related subclinical microemboli are common and their cognitive effects are largely unknown. In this prospective longitudinal study, we sought to determine long-term cognitive effects of embolic infarcts.
Carotid revascularization procedures including carotid endarterectomy (CEA) and carotid artery stenting (CAS) have been shown to be effective in stroke prevention in appropriately selected patients with low perioperative morbidities and mortality. [1] [2] [3] Recent advancements in medical therapy spark controversies on the efficacy of carotid revascularization and intense debates on the best treatment strategies for asymptomatic patients with severe carotid occlusive disease. 4 However, the ongoing debates and most studies evaluating the effectiveness of carotid interventions focus on neurologic outcomes. Neurocognitive outcomes have not been fully considered.
With improved life expectancy and a growing aging population, cognitive dysfunction has become an important global population health concern. Cognitive impairment affects patients, families, and their social networks, representing a significant psychosocial and health economic burden. Patients with carotid occlusive diseases are known to be at the highest risk for cognitive impairment. 5, 6 In recent years, cognitive effects of carotid interventions are increasingly recognized as an important outcome for carotid disease management and carotid interventions. Although revascularization procedures improve cerebral perfusion and theoretically brain health, procedure-related factors, such as microembolization, have been shown to adversely affect cognition after carotid interventions. [7] [8] [9] Procedure-related subclinical embolization can be detected by transcranial Doppler ultrasound 10 and magnetic resonance imaging (MRI) with a diffusion-weighted imaging (DWI) sequence. 11, 12 Subclinical microemboli are common (20%-70%) despite an absence of neurologic symptoms. [13] [14] [15] [16] [17] [18] [19] [20] Studies that evaluated cognitive effects of microembolization have yielded mixed findings. 7, 8, 21, 22 In an experimental animal model, dose-dependent effects of embolization on inflammation and neuronal injury have been observed, and repeated embolization is shown to lead to cognitive impairment. 23 We postulated that the inconsistency in the cognitive effects of subclinical embolization may be related to size of the emboli. To date, there is extremely limited information in the literature on quantification of volumes of procedure-related embolization after carotid revascularization procedures. How the size of emboli influences procedure-related cognitive changes is largely unknown.
In this study, we aimed to evaluate the volume of procedure-related emboli in patients who undergo CEA and CAS, focusing on the effect of volume of emboli on cognitive changes in the CAS cohort.
METHODS
Patient selection. The study was approved by the Stanford Institutional Review Board and VA Palo Alto Health Care System Research and Development Committee. Patients who underwent carotid revascularization procedures for occlusive disease under the standard clinical practice guideline were prospectively recruited. Carotid revascularization was offered to patients with >80% asymptomatic carotid stenosis and >60% symptomatic stenosis based on duplex ultrasound velocity criteria. The degree of stenosis was further confirmed with magnetic resonance angiography or time-of-flight MRI of the neck. For those who underwent CAS, additional contrast angiography was performed before stenting. The decision to perform a CAS procedure was made by a consensus of vascular surgeons, patients, and families; CAS was reserved for patients who were deemed at high surgical or medical risk for CEA. Inclusion criteria for this study also required the patients to be 40 years of age or older, to have absence of psychiatric disorder or medical condition affecting cognitive function, to voluntarily participate in the study, to be able to sign an Institutional Review Board-approved informed consent, to be able to undergo MRI, and to be available for follow-up neuropsychological testing. Demographics and clinical risk factors were documented. Patients were considered to be symptomatic (prior symptoms) if they had experienced transient ischemic attack, amaurosis fugax, or stroke within 6 months leading to their referral for carotid revascularization evaluation.
Carotid intervention. All procedures were performed by experienced vascular surgeons who are proficient in CEA and CAS. All patients received intra-arterial blood pressure monitoring during the procedures. Anesthesiologists were present during the entire CEA and the critical portion of CAS procedures. CEAs were performed under general anesthesia in an operating room with cerebral oximetry monitoring. Shunts and patch were routinely used. The choices of shunt or patch were at the discretion of the operating surgeons. All CAS procedures were performed in an endovascular suite under local anesthesia with conscious sedation. Arch angiography was not routinely performed to avoid unnecessary arch manipulation, and common carotid artery cannulation was based on information from preoperative magnetic resonance angiography using a telescope technique. All patients received a distal embolic protection device before stent placement. Poststent dilation was performed for >30% residual stenosis. After CEA and CAS, all patients were monitored in the surgical intensive care unit overnight. The majority of the patients were discharged home the following day.
Imaging evaluations. Preoperative and postoperative 3T MRI scans (GE Medical Systems, Milwaukee, Wisc) with DWI sequence were performed to identify periprocedural embolic infarcts. MRI studies were performed within 1 to 2 weeks before carotid revascularization and within 24 to 48 hours postoperatively before discharge. Postoperative DWI sequence images and apparent diffusion coefficient maps were compared with the corresponding preoperative images to identify interval, 24 which then incorporated slice thickness and interslice gap to calculate the volume of each infarct as well as their combined volume. Infarct distribution was analyzed using FMRIB Software Library analytical tools. 25 Infarct analysis was performed under the supervision of board-certified neuroradiologists.
ARTICLE HIGHLIGHTS
Cognitive evaluations. All patients underwent a battery of neurocognitive tests at 1 to 2 weeks before and 1 month and 6 months after carotid revascularization procedures. The battery was designed to be briefly and reliably administered by trained research personnel. The Mini-Mental State Examination was performed to assess gross cognition and to screen patients for severe cognitive deficits. The key outcome measure was the Rey Auditory Verbal Learning Test (RAVLT). RAVLT is a verbal learning test that assesses declarative memory. Word list learning is extremely sensitive in discriminating healthy older adults from nondemented older adults with focal memory dysfunction. 26 RAVLT consists of a list of 15 nouns read aloud, at 1-second intervals, for five consecutive trials, with each trial followed by a free recall test. The critical measure was immediate recall task, in which the correct numbers of items recalled over all the learning trials are combined into a sum (RAVLTsum). The order of presentation of words remained fixed across trials. On completion of trial 5, an interference list of 15 words was presented, followed by a free recall test for the interference list. Immediately after this, delayed recall of the original list was tested without further presentation of the original word list (RAVLT short delay [SD] ). After a 20-minute delay period, each subject was again asked to recall the original list, without further presentation of those words (RAVLT long delay [LD]). Three parallel forms of RAVLT were used across the three test sessions to minimize the practice effect. Cognitive decline was defined as negative change in RAVLT from preoperative to postoperative tests. To avoid anesthesiaand surgery-related effects, we evaluated postoperative change at 1 month after interventions. Given our population of elderly patients, a natural age-related decline is expected in our cohort. Therefore, a 6-month follow-up was chosen to assess long-term procedure-related changes.
Statistics. Descriptive analyses were performed for preoperative differences between CAS and CEA cohorts using Student t-test, Pearson c 2 , or Fisher exact test when appropriate. Differences in cognitive scores across different time points were compared using paired sample t-tests, and cognitive scores in patients with and without emboli were compared using two-sampled t-tests with Welch correction. Variables predicting volume of infarct were analyzed using multiple regression and stepwise multiple regression. Logistic regression was used to identify variables predicting the presence of emboli. Relationships between embolic volume and cognitive scores were compared using pairwise 
RESULTS
A total of 119 patients including 55 (46%) symptomatic patients were prospectively enrolled. Demographic and medical comorbidities are listed in Table I . CAS patients had higher incidence of coronary artery disease (58.7% vs 28.6%; P ¼ .003), chronic renal insufficiency (34.9% vs 9.1%; P < .001), and contralateral carotid artery occlusion or severe stenosis (21% vs 5.4%; P ¼ .02). There was no difference in age, education level, or hypertension with a systolic blood pressure (SBP) $140 mm Hg or in histories of atrial fibrillation, chronic obstructive pulmonary disease, diabetes, or obesity between the two groups. Use of antiplatelet therapy and preoperative symptomatic status were also similar between the two groups. In addition, the baseline cognitive scores represented by RAVLTsum, RAVLT SD, and RAVLT LD were similar between the two groups. There were five (4.2%) patients, including four symptomatic patients, who had postoperative neurologic complications, four of which occurred in the CAS cohort. Among the five patients, four had transient neurologic symptoms postoperatively and one had stroke. We observed an improved mean RAVLTsum score, albeit nonsignificant at both 1 month and 6 months after CAS. There was a significant improvement in RAVLTsum at 1 month (38.2 vs 35.9; P ¼ .015) after CEA. The direction of improvement remained but was nonsignificant at 6 months after CEA, suggesting positive effects of carotid interventions on verbal learning memory function (Fig 1) .
There were 115 patients, including 55 CEA patients and 60 CAS patients, who had preoperative and postoperative MRI scans of sufficient quality for quantitative analysis. A total of 587 new lesions were identified on postoperative DWI sequence images, indicative of embolic infarcts. The cumulative volume of infarct was 29,327 mm were present in 49 (81.7%) CAS patients (Fig 2, a) . The , and 1898 mm 3 . Multivariate logistic regression analysis showed that CAS is the only independent predictor of presence of procedure-related embolic infarct (odds ratio, 6.6; confidence interval, 2.1-20.4; P ¼ .001). Multiple regression analysis showed that CAS and contralateral carotid occlusion or severe stenosis were independent predictors of volume of infarction (P ¼ .004 and .02, respectively), whereas hypertension (SBP >140 mm Hg) was protective (P ¼ .037). Because the distribution of volume turned out to be highly skewed with a long upper tail, we performed a cube root transformation of volume (Fig 2, b) . We confirmed that CAS was an independent predictor of higher infarct volume (P ¼ .004), and contralateral carotid artery occlusion or stenosis and diabetes had a trend of positive association with infarct volume (P ¼ .09 and .1, respectively), whereas baseline SBP >140 mm Hg had a negative trend (P ¼ .1; Table II) . Patients with embolic infarcts had significantly decreased RAVLT SD at 1 month postoperatively compared with those without embolic infarcts (change score, À0.45 vs 0.48; P ¼ .048). However, there was no significant difference in change scores of RAVLTsum or RAVLT LD at 1 month or 6 months between patients with and patients without infarction. When examining the infarct volume, we observed a significant correlation between infarct volumes and changes in RAVLT LD at 1 month and 6 months after interventions, particularly among those with procedure-related embolization (R ¼ À0.49 and À0.48; P < .001 and .001, respectively; Fig 2, c) . We also observed a significant correlation between infarct volume and change in RAVLTsum at 6 months after intervention (R ¼ À0.32; P ¼ .04). Similar nonsignificant trends of negative correlation for other RAVLT measures were also observed.
To better decipher the effects of embolic volume, the CAS patients were further divided into three cohorts based on procedure-related infarct volume >500 mm 3 (n ¼ 19), 500 to 100 mm 3 (n ¼ 23), and <100 mm 3 (n ¼ 18). There was no significant difference in demographics, medical comorbidities, preoperative symptoms, or baseline memory scores among the three groups except that the group with high volume of infarction had lower incidence of SBP >140 mm Hg. The patients who suffered from high volume of infarction had lower incidence of preoperative SBP $140 mm Hg compared with low and medium groups (16% vs 33% and 52%; P ¼ .05; Table III ). We observed a nonsignificant trend of improvement in RAVLTsum among patients with low and medium infarct volumes compared with those with high volume of infarction both at 1 month (2 and 1 vs À0.5, respectively) and at 6 months (2.4 and 1 vs À0.5, respectively) after interventions. We also observed a similar trend for RAVLT LD, whereas RAVLT SD showed a significant difference in changes at 1 month (P ¼ .05) and near significance at 6 months after intervention (P ¼ .07) between low (<100 mm 3 ) and high (>500 mm 3 ) groups (Fig 3, a) . We also observed that a higher proportion of patients experienced >10% of decline in RAVLTsum in the high-volume group compared with lower volume groups both at 1 month (47%, 37%, and 18%, respectively) and at 6 months after interventions (50%, 46%, and 25%, respectively; Fig 3, b) . Furthermore, a significant correlation was observed between infarct volume and changes in RAVLT SD both at 1 month and at 6 months after CAS (R ¼ À0.34 and À0.36; P ¼ .021 and .026, respectively; Fig 3, c) . Similar nonsignificant negative correlations were observed for RAVLTsum and RAVLT LD.
DISCUSSION
In this prospective longitudinal evaluation, we evaluated infarct volume after carotid interventions and related the size of infarct to long-term cognitive change after CAS procedures. To our knowledge, this is the first study demonstrating a significant correlation between volumes of procedure-related infarct and cognitive outcomes in patients with severe carotid occlusive disease who underwent carotid revascularizations.
Cognitive impairment is increasingly recognized as a major public health and socioeconomic concern. 27, 28 A large natural history study on cognitive function in elderly individuals by Bennett et al showed an annual rate of decline ranging from 0.021 standard unit for episodic memory to 0.037 for semantic memory among individuals without baseline mild cognitive impairment (MCI) and an even faster decline rate among those with MCI. 29 The patients with baseline MCI had 1.7 times higher mortality and 3.1 times faster progression to dementia. Patients with carotid occlusive diseases are known to be at the highest risk for cognitive impairment. [30] [31] [32] Using three parallel forms to minimize practice effect, we observed a positive effect of carotid intervention on verbal learning memory, suggesting that carotid revascularization may temporize the natural deterioration of cognitive function in elderly patients with severe carotid stenosis. Although procedure-related subclinical embolization has been implied in cognitive deterioration after carotid interventions, conflicting findings in the literature have led to persistent debate on the cognitive effects of subclinical embolization. 7, 8, 33, 34 In experimental models, several investigators have shown that embolization can lead to neuronal damage and that degree of cognitive impairment correlates to the size of embolization in rats. 9, 23, 35 Our finding confirms the laboratory investigations and, for the first time, showed that volume of infarction significantly influences long-term cognitive effects in patients who underwent carotid interventions. We showed that patients with medium and high infarct volumes had memory deterioration in various RAVLT measures, whereas those with low volume did not experience the same extent of cognitive insult. This study provides objective evidence that subclinical embolization contributes to heterogeneous cognitive outcomes after carotid interventions, suggesting that the higher percentage of cognitive decline in patients who receive CAS may be due to higher procedure-related subclinical embolization. Consistent with our previous studies and others, we showed that procedure-related subclinical embolization is common after carotid interventions, particularly CAS. 7, 20, 36, 37 However, we observed a high incidence of DWI lesions in both CEA and CAS groups in this study. We attributed this to our high percentage of symptomatic patients of nearly 50%, dedicated neuroradiologists, and 3T MRI techniques. There was no change in patient selection, practice pattern, or clinical personnel from our previous studies; 3T MRI provides a higher resolution power for DWI lesion identification and measurement, and each lesion was carefully traced and evaluated by the study team. Despite a higher incidence of DWI lesions observed on 3T in our study cohort, only three patients experienced neurologic complications. Similar observation was reported by Bonati et al in the International Carotid Stenting Study (ICSS). The authors showed higher numbers of new DWI lesions detected on 3T than on 1.5T MRI (44% vs 31%) despite there being more CEA patients in the 3T MRI group. 20 In addition to CAS procedure, we also observed that contralateral carotid stenosis or occlusion showed a trend association with larger infarct volume, whereas SBP $140 mm Hg was protective in patients with severe carotid stenosis who undergo carotid interventions, suggesting that low cerebral perfusion pressure subjects this group of patients to larger infarct volume and consequent cognitive decline after carotid interventions. Despite numerous strengths, the study is not without limitations. This is a single-center, nonrandomized study. We examined difference between CEA and CAS, but CAS is reserved for high surgical risk patients. Although there was no difference in baseline preoperative symptomatic status, age, and memory scores between CAS and CEA patients, the two cohorts were not entirely comparable. Therefore, to understand procedure-related infarction, we separately evaluated the CAS cohort. Another concern is that there is no control for our study. Bennett et al have shown a consistent cognitive deterioration in episodic and semantic memories in a population with similar age and education levels. We expect that patients with carotid disease have more rapid cognitive decline. Future studies with a control cohort of patients with severe carotid stenosis who undergo unrelated procedures are needed to further validate our findings on cognitive benefits of carotid interventions. Furthermore, our study subjects are recruited from a Veterans Health Administration hospital system that is composed of predominantly male patients; therefore, our findings may not apply to female patients. Last, although our study is one of the largest comprehensive evaluations of procedure-related embolization, the total number is relatively small; a larger multicenter study is warranted to further validate these findings.
CONCLUSIONS
Carotid stenting and baseline low cerebral perfusion are predictors of high volume of embolic infarct associated with carotid revascularization procedures. Subclinical embolization is not benign, and volume of infarction directly influences cognitive outcome of procedurerelated embolization. Cognitive evaluation should be considered in carotid disease management. Fig 3. a, Changes in Rey Auditory Verbal Learning Test short delay recall (RAVLT SD) scores among carotid artery stenting (CAS) patients who experienced low, medium, and high volumes of procedure-related infarction. There was a significant difference in changes at 1 month (P ¼ .05) and nearly significant change at 6 months after intervention (P ¼ .07) between low-volume (<100 mm 3 ) and high-volume (>500 mm 3 ) groups. b, A higher proportion of CAS patients experienced >10% of cognitive changes in the high embolic group compared with the low embolic groups both at 1 month and at 6 months after carotid stenting. c, A significant negative correlation was observed between infarct volume (cube root transformation) and changes in RAVLT SD at 1 month and 6 months after carotid stenting. RAVLTsum, Sum of RAVLT trial scores.
